Metformin Treatment Represses Vascular Endothelial Growth Factor Gene Transcription in MCF-7 Breast Cancer Cells

Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 3

Abstract

Background/Aim:Targeting angiogenesis preferentially in cancer is a promising approach to improve treatment efficacy and safety. The aim of this study is investigate potential upregulation of Krüppel like factor-4(KLF-4) by inhibition of mammalian target of rapamycin (mTOR) to repress vascular endothelial growth factor (VEGF) expression in breast cancer cells. Materials and Methods: Using Western blot; bandshift assay; and Chloramphenicol acetyltransferase assay, we assessed the effect of different mTOR inhibitors on the level of mTOR pathway proteins and on KLF-4/ serum amyloid activating factor (SAF-1) SAF-1 DNA binding and consequently VEGF gene expression in MCF-7breast cancer cells. Results: mTOR inhibition increased KLF-4 level in breast cancer cells, but this inhibition, except for metformin, elicited rebound upregulation of mTOR signaling proteins. Thus metformin produced a sustained increase in KLF-4 level and concomitant disruption of SAF-1 binding to VEGF promoter with consequent inhibition of VEGF expression. Conclusion:Repurposing metformin as a potential neoadjuvant and antiangiogenic treatment could provide the basis for more effective and safer antiangiogenic treatment.

Authors and Affiliations

Mohamed Alalem, Bimal K Ray

Keywords

Related Articles

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Checkpoint inhibitors have demonstrated efficacy in squamous NSCLC with tolerable toxicity profile. They are used as a monotherapy, in combination with chemotherapy or following chemo-radiotherapy as a first line, second...

Micro-Environmental Systems and Endothelial Cells in Cooperative Tumorigenesis Account for Potential Malignant Transformation in Neurofibromatosis Type 1 Patients

Overall tumorigenesis in neurofibromatosis type 1 patients constitutes a series of specific targeting events with a central role enacted by proliferation of fibroblasts and endothelial cells in overproduction of growth f...

The Potential Role of Thioctic Acid in the Attenuation of Doxorubicin Induced-Cardiotoxicity

During 1950s in Italy a soil sample was isolated and found new strains of Streptomyces peucetius bacteria from which a new antibiotic was extracted with potent effect against murine tumors, this antibiotic named daunorub...

Metastatic Hormone and Her-2 Positive Breast Cancer: A Community Approach

Metastatic hormone-receptor and HER-2 positive (triple-positive) breast cancer provides a treatment dilemma for clinicians. The current guidelines offer a variety of options in the first and second line for metastatic br...

Permissiveness Paradox in Cell Cycle Progression Towards Genome Instability and Malignant Transformation

Dimensional representation of events actively executing the cell cycle dynamics of progression in carcinogenesis allow for a paradoxical emergence of highly permissive elements in the establishment of the mitotic spindle...

Download PDF file
  • EP ID EP586783
  • DOI 10.32474/OAJOM.2018.01.000115
  • Views 63
  • Downloads 0

How To Cite

Mohamed Alalem, Bimal K Ray (2018). Metformin Treatment Represses Vascular Endothelial Growth Factor Gene Transcription in MCF-7 Breast Cancer Cells. Open Access Journal of Oncology and Medicine, 1(3), 61-67. https://europub.co.uk/articles/-A-586783